BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 26117254)

  • 1. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases.
    Matsushita K; Kato Y; Akasaki S; Yoshimoto T
    Allergol Int; 2015 Jul; 64(3):235-40. PubMed ID: 26117254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
    Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
    Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
    Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
    Tojima I; Shimizu T
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group 2 innate lymphoid cells in nasal polyposis.
    Stevens WW; Kato A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
    Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
    Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
    Lee M; Kim DW; Shin HW
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis.
    Ryu G; Kim DW
    Curr Opin Allergy Clin Immunol; 2020 Feb; 20(1):1-8. PubMed ID: 31567293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic inflammation is exacerbated by allergen-induced type 2 innate lymphoid cells in a murine model of allergic rhinitis.
    Lin L; Dai F; Wei JJ; Tang XY; Chen Z; Sun GB
    Rhinology; 2017 Dec; 55(4):339-347. PubMed ID: 28689218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
    Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
    Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.
    Bal SM; Bernink JH; Nagasawa M; Groot J; Shikhagaie MM; Golebski K; van Drunen CM; Lutter R; Jonkers RE; Hombrink P; Bruchard M; Villaudy J; Munneke JM; Fokkens W; Erjefält JS; Spits H; Ros XR
    Nat Immunol; 2016 Jun; 17(6):636-45. PubMed ID: 27111145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis.
    Zhu YQ; Liao B; Liu YH; Wang Z; Zhu XH; Chen XB; Wang MQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4097-4109. PubMed ID: 31173279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of type 2 innate lymphoid cells in the pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyps].
    Geng CL; Xing ZM; Yu LS; Wang M; Yuan XP; Liu Y; Zhang G; Wang ZJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):369-374. PubMed ID: 29764019
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Allergic Rhinitis in Chronic Rhinosinusitis.
    Helman SN; Barrow E; Edwards T; DelGaudio JM; Levy JM; Wise SK
    Immunol Allergy Clin North Am; 2020 May; 40(2):201-214. PubMed ID: 32278445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitis.
    Peng YQ; Qin ZL; Fang SB; Xu ZB; Zhang HY; Chen D; Liu Z; Bellanti JA; Zheng SG; Fu QL
    J Allergy Clin Immunol; 2020 Mar; 145(3):855-867.e8. PubMed ID: 31812574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Lin L; Chen Z; Dai F; Wei JJ; Tang XY; Sun GB
    Auris Nasus Larynx; 2019 Aug; 46(4):533-541. PubMed ID: 30554982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
    Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
    Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells.
    Ramanathan M; Lee WK; Spannhake EW; Lane AP
    Am J Rhinol; 2008; 22(2):115-21. PubMed ID: 18416964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.